Tenaya Therapeutics, Inc.
TNYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $8,468 | $8,687 | $8,713 | $4,025 |
| Gross Profit | -$8,468 | -$8,687 | -$8,713 | -$4,025 |
| % Margin | – | – | – | – |
| R&D Expenses | $86,742 | $98,038 | $94,537 | $54,393 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $20,738 | $24,468 | $22,371 | $14,388 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $107,480 | $122,506 | $116,908 | $68,781 |
| Operating Income | -$115,948 | -$131,193 | -$125,621 | -$72,806 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $4,819 | $7,109 | $1,956 | $85 |
| Pre-Tax Income | -$111,129 | -$124,084 | -$123,665 | -$72,721 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$111,129 | -$124,084 | -$123,665 | -$72,721 |
| % Margin | – | – | – | – |
| EPS | -1.31 | -1.68 | -2.76 | -1.69 |
| % Growth | 22% | 39.1% | -63.3% | – |
| EPS Diluted | -1.31 | -1.68 | -2.76 | -1.69 |
| Weighted Avg Shares Out | 84,822 | 73,786 | 44,824 | 41,291 |
| Weighted Avg Shares Out Dil | 84,822 | 73,786 | 44,824 | 41,291 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,737 | $7,056 | $1,954 | $108 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $8,468 | $8,687 | $8,713 | $4,025 |
| EBITDA | -$102,661 | -$115,397 | -$114,952 | -$68,696 |
| % Margin | – | – | – | – |